Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
14 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Yescarta“
Suchtreffer
Begriffe & Kennungen
Yescarta · 4.8 · Table 1: Adverse drug reactions identified with Yescarta
Eintrag öffnenYescarta · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenYescarta · 4.8 · The immunogenicity of Yescarta has been evaluated using an enzyme-linked immunosorbent assay (ELISA) for the d
Eintrag öffnenYescarta · 4.8 · The most common (≥ 5%) Grade 3 or higher non-haematological adverse reactions included encephalopathy (14%), u
Eintrag öffnenYescarta · 4.8 · The most common (≥ 5%) Grade 3 or higher non-haematological adverse reactions included encephalopathy (19%), u
Eintrag öffnenYescarta · 4.8 · The most common (≥ 5%) Grade 3 or higher non-haematological adverse reactions included encephalopathy (31%), u
Eintrag öffnenYescarta · 4.8 · The most common (≥ 5%) neurologic adverse reactions included encephalopathy (51%), tremor (28%), and delirium
Eintrag öffnenYescarta · 4.8 · The most common adverse reactions (≥ 20%) that may be associated with CRS included pyrexia (89%), hypotension
Eintrag öffnenYescarta · 4.8 · The most significant and frequently occurring adverse reactions were CRS (77%), infections (59%), and encephal
Eintrag öffnenYescarta · 4.8 · The most significant and frequently occurring adverse reactions were CRS (92%), encephalopathy (49%), and infe
Eintrag öffnenYescarta · 4.8 · The most significant and frequently occurring adverse reactions were CRS (93%), encephalopathy (60%), and infe
Eintrag öffnenYescarta · 4.8 · The safety data described in this section are from a total of 397 adult patients treated with Yescarta in thre
Eintrag öffnenYescarta · 4.8 · There is limited experience with Yescarta in patients ≥ 75 years of age. Generally, safety and efficacy were s
Eintrag öffnenYescarta · 4.8 · a. Coagulopathy includes coagulopathy, blood fibrinogen decreased, blood fibrinogen increased, disseminated in
Eintrag öffnen